Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose
New Delhi: Hyderabad-based pharmaceutical company Biological E has sought permission from the Drugs Controller General of India (DCGI) to conduct the phase-3 clinical trials for its Covid-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin....









































